Podcast 30: Dr. Roger Chou of Oregon Health Sciences University talks about recent guidelines for opioid use in non-cancer pain and reflects on the FD...

The FDA announced an early-March meeting with manufacturers of opioids to discuss how problems with the drugs’ overuse and abuse might be addressed. We talk with an author of guidelines just published (and freely available) in the Journal of Pain that coincidentally address some of these concerns. Then, of course, there’s the usual news roundup, and we finish off with a 200th birthday salute to Charles Darwin (no thanks to unevolved Americans). To join the merriment or complain about the cake, call 617-440-4374 and leave a message. To trace the evolution of “Admitting Diagnosis,” which we admit is horribly misnamed, go to podcasts.jwatch.org. Links for this edition: Severe Ankle Sprains Respond Best to Immobilization in the Short Term Multivitamin Use Not Associated with Lower Risk for Cancer or CVD in Women FDA to Tighten Opioid Restrictions Guidelines on Opioids in Noncancer Pain Issued The post Podcast 30: Dr. Roger Chou of Oregon Health Sciences University talks about recent guidelines for opioid use in non-cancer pain and reflects on the FDA’s recent announcement of tighter regulation on use of the drugs. first appeared on Clinical Conversations.